Anders Ullén
Impact in
Papers in
- Surgery 45
- Bladder and Urothelial Cancer Treatments 45
- Urinary and Genital Oncology Studies 9
-
- Prostate Cancer Treatment and Research 12
- Renal cell carcinoma treatment 6
- Prostate Cancer Diagnosis and Treatment 5
- Co-authors
- Sten Nilsson (17 shared papers)Amir Sherif (15 shared papers)Per‐Uno Malmström (10 shared papers)Robert Rosenblatt (3 shared papers)Rolf Wahlqvist (2 shared papers)Erkki Rintala (1 shared paper)Theocharis Panaretakis (6 shared papers)Lena Lennartsson (5 shared papers)
- Journals
- Acta Oncologica (10 papers)Journal of Clinical Oncology (6 papers)European Urology (6 papers)Cancer (5 papers)European Journal of Cancer (4 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Anders Ullén
84 papers receiving 1.4k citations
Anders Ullén's Hit Papers
Peers
Comparison fields: 5 of 81
- Surgery 629
- Oncology 338
- Cancer Research 175
- Pulmonary and Respiratory Medicine 285
- Urology 51
Countries citing papers authored by Anders Ullén
This map shows the geographic impact of Anders Ullén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Ullén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Ullén more than expected).
Fields of papers citing papers by Anders Ullén
This network shows the impact of papers produced by Anders Ullén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Ullén. The network helps show where Anders Ullén may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Ullén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 203 | |
| 2 | 2015 | 132 | |
| 3 | Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up Hit paper breakdown → | 2023 | 124 |
| 4 | 2021 | 98 | |
| 5 | 2005 | 60 | |
| 6 | 2020 | 57 | |
| 7 | 2016 | 55 | |
| 8 | 2012 | 50 | |
| 9 | 2011 | 37 | |
| 10 | 2023 | 33 | |
| 11 | 2016 | 32 | |
| 12 | 2015 | 27 | |
| 13 | 2014 | 26 | |
| 14 | 2017 | 23 | |
| 15 | 2008 | 22 | |
| 16 | 2020 | 21 | |
| 17 | Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization. | 1995 | 20 |
| 18 | 2021 | 19 | |
| 19 | 2019 | 19 | |
| 20 | 2019 | 18 |
About Anders Ullén
Anders Ullén is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 94 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (45 papers), Radiopharmaceutical Chemistry and Applications (16 papers), Prostate Cancer Treatment and Research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Urinary and Genital Oncology Studies (9 papers), Renal cell carcinoma treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Surgery (629 citations), Oncology (338 citations), Cancer Research (175 citations), Pulmonary and Respiratory Medicine (285 citations) and Urology (51 citations). Anders Ullén has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Sten Nilsson, Amir Sherif, Per‐Uno Malmström, Robert Rosenblatt, Rolf Wahlqvist, Erkki Rintala, Theocharis Panaretakis, Lena Lennartsson, Jeffrey Yachnin and Pedro Fonseca. Their work appears in journals such as Acta Oncologica, Journal of Clinical Oncology, European Urology, Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.